StockNews.com upgraded shares of Orthofix Medical (NASDAQ:OFIX – Free Report) from a hold rating to a buy rating in a report published on Friday. Other equities analysts have also recently issued ...
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February 25, ...
89.76% of the stock is owned by institutional investors and hedge funds. Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom ...
Hosted on MSN15d
Canaccord Genuity Initiates Coverage of Orthofix Medical (OFIX) with Buy RecommendationFintel reports that on January 22, 2025, Canaccord Genuity initiated coverage of Orthofix Medical (NasdaqGS:OFIX) with a Buy recommendation. Analyst Price Forecast Suggests 35.56% Upside As of ...
Atalanta Therapeutics is pioneering RNA interference (RNAi) for the treatment of neurological diseases, having developed a proprietary platform that, for the first time enables RNAi to be deployed as ...
PORTLAND, IL, UNITED STATES, January 30, 2025 /EINPresswire / -- Increase in the number of spinal & joint <a target=_blank href= ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback